CDKN2A and acute lymphoblastic leukemia: p16γ is highly expressed at transcription and translation levels in primary T-ALL patients and neuroblastoma cell lines, and at low levels in other samples of primary T-ALL and B- lineage -ALL patients expressing p16INK4A.